Epidemiology Midterm
and Final Exam Questions
and Answers Updated
2027
OddsBRatioB-BAnswerB(NumberBofBpairsBwithBcaseBexposedBandBcontrolBnon-
exposed)/(NumberBofBpairsBwithBcontrolBexposedBandBcaseBnon-exposed)
ProportionateBMortalityB-
BAnswerB(Num.BofBdeathsBdueBtoBaBspecificBdiseaseBinBaBpopulationBatBaBspecificBti
me)/(TotalBdeathsBinBtheBpopulationBatBtheBsameBtime)BXB100
AnnualBMortalityBRateB-
BAnswerB(TotalBnumberBofBdeathsBfromBallBcausesBinB1Byear)/(NumberBofBpersonBiBt
heBpopulaitonBatBmidyear)BXB1,000
RelativeBSurvivalB-
BAnswerB(ObservedBsurvivalBinBpersonsBwithBtheBdisease)/(ExpectedBsurvivalBifBdiseas
eBwereBabsent)BXB1,000
CrudeBMortalityBRateB-
BAnswerB(TotalBnumberBofBdeathsBfromBallBcausesBforBaBspecifiedBtimeBperiod)/(Total
BpopulationBforBtheBsameBgeographicBareaBforBspecifiedBtimeBperiod)BXB100,000
Case-FatalityB-
BAnswerB(Num.ofBpersonsBdyingBduringBaBspecifiedBtimeBperiodBafterBaBspecificBdise
aseBonset)/(Num.ofBpersonsBwithBtheBdiseaseB)BXB100
,StandardizedBMortalityBRatioB-
BAnswerB(ObservedBnumberBofBDeathsBperByear)/(ExpectedBnumberBofBDeathsBperBy
ear)BXB100
IncidenceBRateB-
BAnswerB(Num.BofBnewBcasesBofBaBdiseaseBoccuringBinBaBpopulationBduringBaBspecif
iedBtimeBperiod)/(Num.ofBpersonsBatBriskBofBdevelopingBdiseaseBduringBtheBsameBtim
eBperiod)BXB1,000
PrevalenceB-
BAnswerB(NumberBofBcasesBofBaBdiseaseBpresentBinBaBpopulationBatBaBspecifiedBtim
e)/(NumberBofBpersonsBinBaBpopulationBatBtheBsameBspecifiedBtime)BXB1,000
KAPPABStatisticB-BAnswerB((PercentBagreementBobserved-
PercentBagreementBexpectedBbyBchanceBalone)B)/((100%-
PercentBagreementBexpectedBbyBchance))
RelativeBRiskB(RiskBRatio)B-BAnswerB(IncidenceBinBExposedB)/(IncidenceBinBtheBnon-
exposed)
CauseBSpecificBMortalityBRateB-
BAnswerB(NumberBofBDeathsBdueBtoBaBspecificBdiseaseBinBaBpopulationBatBaBspecific
Btime)/(TotalBpopulationBatBtheBsameBspecifiedBtime)BXB1,000
AttackBRateB-
BAnswerB(NumberBofBpeopleBatBriskBwhoBdevelopBanBillnessBorBdiseaseBoverBaBshor
tBtimeBperiodB)/(TotalBNumberBofBpersonsBatBriskBforBtheBillnessBorBdiseaseBoverBthe
BsameBtimeBperiod)
SecondaryBAttackBRateB-
BAnswerB(NumberBofBcasesBamongBsusceptibleBcontactsBofBtheBprimaryBcasesB)/(Total
BnumberBofBcontactsBexposed)BXB1,000
,SensitivityB-
BAnswerB(NumberBofBpeopleBwhoBtestBpositiveB)/(NumberBofBpeopleBwithBdiseaseB)B
XB100
SpecificityB-
BAnswerB(NumberBofBpeopleBwhoBtestBnegativeB)/(NumberBofBpeopleBdiseaseBfree)B
XB100
OddsBratio-matchedB-BAnswerB(NumberBofBpairsBwithBcaseBexposedBandBcontrolBnon-
exposed)/(NumberBofBpairsBwithBcontrolBexposedBandBcaseBnon-exposed)
OddsBRatioB-
BAnswerB(OddsBofBexposureBamongBdiseasedB)/(OddsBofBexposureBamongBnon-
diseased)
WhichBstatementBconveysBtheBunderlyingBpremiseBinBepidemiology?B-
BAnswerBDiseaseB(illBhealth)BisBnotBrandomlyBdistributedBinBpopulationsBbyBperson,Bt
ime,BandBplace
TheBSpanishBFluBofB1917BisBanBexampleBofBa(n)B___________,BbecauseBofBitsBworld
wideBoccurrence.B-BAnswerBPandemic
((𝑁𝑢𝑚𝑏𝑒𝑟B𝑜𝑓B𝑁𝐸𝑊B𝑐𝑎𝑠𝑒𝑠B𝑜𝑓B𝑎B𝑑𝑖𝑠𝑒𝑎𝑠𝑒B𝑜𝑣𝑒𝑟B𝑎B𝑡𝑖𝑚𝑒B𝑝𝑒𝑟𝑖𝑜𝑑)/(𝑃𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛B𝑎𝑡B𝑟𝑖𝑠
𝑘B))∗1000B-BAnswerBIncidenceBRate
SensitivityBandBSpecificityBareBmeasuresBofB_________,BoftenBassociatedBwithB______
_________:B-BAnswerBValidityB/BScreeningBTests
InBtheBpriorBquestion,BitBwasBnotedBthatBtheBRelativeBRiskBwasB5.0.BHowBwouldByou
BinterpretBthisBstatistic?
, a)BPositiveBAssociation;BexposedBpeopleBareBatBgreaterBriskBtoBtheBoutcomeBcompare
BtoBnon-exposedBpeople
b)BNegativeBAssociation;BexposedBpeopleBhaveBaBnegativeBexperience
c)BPositiveBAssociation;BexposedBpeopleBareBexactlyB5%BmoreBlikelyBtoBexperienceBth
eBoutcomeB
d)BNegativeBAssociation;BexposedBpeopleBareBexactlyB5BtimesBmoreBlikelyBtoBexperien
ceBtheBoutcomeB-
BAnswerBa)BPositiveBAssociation;BexposedBpeopleBareBatBgreaterBriskBtoBtheBoutcome
BcompareBtoBnon-exposedBpeople
InB2003BanBepidemicBofBSARsBoccurred.BDuringBtheBepidemicB8098BpeopleBwereBdia
gnosedBwithBSARS,BofBwhichB774BdiedBasBaBresult.BBasedBonBthisBinformationBwhich
BstatisticBcanByouBcalculate?B
a)BMortalityBRate
b)BCase-FatalityB
c)BPerson-TimeBIncidenceB
d)BPrevalenceB-BAnswerBb)BCase-Fatality
Case-
FatalityBandBMortalityBRateBshareBtheBsameB_________,BbutBhaveBdifferentB________
______:
a)BNumerator,BDenominatorsB
b)BDenominator,BNumerator
c)BMorbidBCuriosity,BMeanings
d)BProportion,BInterpretationsB-BAnswerBa)BNumerator,BDenominators
ABcohortBstudyBenrollsBitsBparticipantsBbyB_______BandBthenBmeasuresBtheB_______
_.B
and Final Exam Questions
and Answers Updated
2027
OddsBRatioB-BAnswerB(NumberBofBpairsBwithBcaseBexposedBandBcontrolBnon-
exposed)/(NumberBofBpairsBwithBcontrolBexposedBandBcaseBnon-exposed)
ProportionateBMortalityB-
BAnswerB(Num.BofBdeathsBdueBtoBaBspecificBdiseaseBinBaBpopulationBatBaBspecificBti
me)/(TotalBdeathsBinBtheBpopulationBatBtheBsameBtime)BXB100
AnnualBMortalityBRateB-
BAnswerB(TotalBnumberBofBdeathsBfromBallBcausesBinB1Byear)/(NumberBofBpersonBiBt
heBpopulaitonBatBmidyear)BXB1,000
RelativeBSurvivalB-
BAnswerB(ObservedBsurvivalBinBpersonsBwithBtheBdisease)/(ExpectedBsurvivalBifBdiseas
eBwereBabsent)BXB1,000
CrudeBMortalityBRateB-
BAnswerB(TotalBnumberBofBdeathsBfromBallBcausesBforBaBspecifiedBtimeBperiod)/(Total
BpopulationBforBtheBsameBgeographicBareaBforBspecifiedBtimeBperiod)BXB100,000
Case-FatalityB-
BAnswerB(Num.ofBpersonsBdyingBduringBaBspecifiedBtimeBperiodBafterBaBspecificBdise
aseBonset)/(Num.ofBpersonsBwithBtheBdiseaseB)BXB100
,StandardizedBMortalityBRatioB-
BAnswerB(ObservedBnumberBofBDeathsBperByear)/(ExpectedBnumberBofBDeathsBperBy
ear)BXB100
IncidenceBRateB-
BAnswerB(Num.BofBnewBcasesBofBaBdiseaseBoccuringBinBaBpopulationBduringBaBspecif
iedBtimeBperiod)/(Num.ofBpersonsBatBriskBofBdevelopingBdiseaseBduringBtheBsameBtim
eBperiod)BXB1,000
PrevalenceB-
BAnswerB(NumberBofBcasesBofBaBdiseaseBpresentBinBaBpopulationBatBaBspecifiedBtim
e)/(NumberBofBpersonsBinBaBpopulationBatBtheBsameBspecifiedBtime)BXB1,000
KAPPABStatisticB-BAnswerB((PercentBagreementBobserved-
PercentBagreementBexpectedBbyBchanceBalone)B)/((100%-
PercentBagreementBexpectedBbyBchance))
RelativeBRiskB(RiskBRatio)B-BAnswerB(IncidenceBinBExposedB)/(IncidenceBinBtheBnon-
exposed)
CauseBSpecificBMortalityBRateB-
BAnswerB(NumberBofBDeathsBdueBtoBaBspecificBdiseaseBinBaBpopulationBatBaBspecific
Btime)/(TotalBpopulationBatBtheBsameBspecifiedBtime)BXB1,000
AttackBRateB-
BAnswerB(NumberBofBpeopleBatBriskBwhoBdevelopBanBillnessBorBdiseaseBoverBaBshor
tBtimeBperiodB)/(TotalBNumberBofBpersonsBatBriskBforBtheBillnessBorBdiseaseBoverBthe
BsameBtimeBperiod)
SecondaryBAttackBRateB-
BAnswerB(NumberBofBcasesBamongBsusceptibleBcontactsBofBtheBprimaryBcasesB)/(Total
BnumberBofBcontactsBexposed)BXB1,000
,SensitivityB-
BAnswerB(NumberBofBpeopleBwhoBtestBpositiveB)/(NumberBofBpeopleBwithBdiseaseB)B
XB100
SpecificityB-
BAnswerB(NumberBofBpeopleBwhoBtestBnegativeB)/(NumberBofBpeopleBdiseaseBfree)B
XB100
OddsBratio-matchedB-BAnswerB(NumberBofBpairsBwithBcaseBexposedBandBcontrolBnon-
exposed)/(NumberBofBpairsBwithBcontrolBexposedBandBcaseBnon-exposed)
OddsBRatioB-
BAnswerB(OddsBofBexposureBamongBdiseasedB)/(OddsBofBexposureBamongBnon-
diseased)
WhichBstatementBconveysBtheBunderlyingBpremiseBinBepidemiology?B-
BAnswerBDiseaseB(illBhealth)BisBnotBrandomlyBdistributedBinBpopulationsBbyBperson,Bt
ime,BandBplace
TheBSpanishBFluBofB1917BisBanBexampleBofBa(n)B___________,BbecauseBofBitsBworld
wideBoccurrence.B-BAnswerBPandemic
((𝑁𝑢𝑚𝑏𝑒𝑟B𝑜𝑓B𝑁𝐸𝑊B𝑐𝑎𝑠𝑒𝑠B𝑜𝑓B𝑎B𝑑𝑖𝑠𝑒𝑎𝑠𝑒B𝑜𝑣𝑒𝑟B𝑎B𝑡𝑖𝑚𝑒B𝑝𝑒𝑟𝑖𝑜𝑑)/(𝑃𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛B𝑎𝑡B𝑟𝑖𝑠
𝑘B))∗1000B-BAnswerBIncidenceBRate
SensitivityBandBSpecificityBareBmeasuresBofB_________,BoftenBassociatedBwithB______
_________:B-BAnswerBValidityB/BScreeningBTests
InBtheBpriorBquestion,BitBwasBnotedBthatBtheBRelativeBRiskBwasB5.0.BHowBwouldByou
BinterpretBthisBstatistic?
, a)BPositiveBAssociation;BexposedBpeopleBareBatBgreaterBriskBtoBtheBoutcomeBcompare
BtoBnon-exposedBpeople
b)BNegativeBAssociation;BexposedBpeopleBhaveBaBnegativeBexperience
c)BPositiveBAssociation;BexposedBpeopleBareBexactlyB5%BmoreBlikelyBtoBexperienceBth
eBoutcomeB
d)BNegativeBAssociation;BexposedBpeopleBareBexactlyB5BtimesBmoreBlikelyBtoBexperien
ceBtheBoutcomeB-
BAnswerBa)BPositiveBAssociation;BexposedBpeopleBareBatBgreaterBriskBtoBtheBoutcome
BcompareBtoBnon-exposedBpeople
InB2003BanBepidemicBofBSARsBoccurred.BDuringBtheBepidemicB8098BpeopleBwereBdia
gnosedBwithBSARS,BofBwhichB774BdiedBasBaBresult.BBasedBonBthisBinformationBwhich
BstatisticBcanByouBcalculate?B
a)BMortalityBRate
b)BCase-FatalityB
c)BPerson-TimeBIncidenceB
d)BPrevalenceB-BAnswerBb)BCase-Fatality
Case-
FatalityBandBMortalityBRateBshareBtheBsameB_________,BbutBhaveBdifferentB________
______:
a)BNumerator,BDenominatorsB
b)BDenominator,BNumerator
c)BMorbidBCuriosity,BMeanings
d)BProportion,BInterpretationsB-BAnswerBa)BNumerator,BDenominators
ABcohortBstudyBenrollsBitsBparticipantsBbyB_______BandBthenBmeasuresBtheB_______
_.B